The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation.
about
Complementary and alternative medicine treatments for atopic eczemaTopical calcineurin inhibitors for atopic dermatitis: review and treatment recommendationsAtopy and keratoconus: a multivariate analysisTemporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitisGenome-wide comparative analysis of atopic dermatitis and psoriasis gives insight into opposing genetic mechanismsGlobal expression profiling in atopic eczema reveals reciprocal expression of inflammatory and lipid genes.The descriptive epidemiology of atopic dermatitis in the community.Clinical evidence: atopic eczema.Validation of epidemiological tools for eczema diagnosis in Brazilian children: the ISAAC's and UK Working Party's criteriaAtopic dermatitis. Perspectives on a manageable disease.Evaluation of a Pseudoceramide Moisturizer in Patients with Mild-to-Moderate Atopic Dermatitis.Itch and atopic dermatitis: an overview.Atopic dermatitis: from the genes to skin lesions.Eczema.Cutaneous manifestations of DOCK8 deficiency syndromeEffectiveness and cost-effectiveness of daily all-over-body application of emollient during the first year of life for preventing atopic eczema in high-risk children (The BEEP trial): protocol for a randomised controlled trial.Sensitisation to Blattella germanica among adults with asthma in Yaounde, Cameroon: a cross-sectional study.Adult-onset atopic dermatitis.Filaggrin genotype determines functional and molecular alterations in skin of patients with atopic dermatitis and ichthyosis vulgaris.Atopic dermatitis and fungi.Clinical aspects of atopic dermatitis.Validation and refinement of the Millennium Criteria for atopic dermatitis.A phase I study of daily treatment with a ceramide-dominant triple lipid mixture commencing in neonatesThe effects of treatment on itch in atopic dermatitisReduced gut microbial diversity in early life is associated with later development of eczema but not atopy in high-risk infants.Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis.Anti-IL-31 receptor antibody is shown to be a potential therapeutic option for treating itch and dermatitis in miceOat sensitization in children with atopic dermatitis: prevalence, risks and associated factors.Perinatal predictors of atopic dermatitis occurring in the first six months of lifeDiagnostic criteria for atopic dermatitis: a systematic review.TOPICOP©: a new scale evaluating topical corticosteroid phobia among atopic dermatitis outpatients and their parentsThe altered landscape of the human skin microbiome in patients with primary immunodeficiencies.DNA methylation of Th2 lineage determination genes at birth is associated with allergic outcomes in childhood.Gender differences in depression and anxiety among atopic dermatitis patients.Skin barrier dysfunction measured by transepidermal water loss at 2 days and 2 months predates and predicts atopic dermatitis at 1 yearA possible association between a dysfunctional skin barrier (filaggrin null-mutation status) and diabetes: a cross-sectional study.Intragenic copy number variation within filaggrin contributes to the risk of atopic dermatitis with a dose-dependent effectClinical Parameters vs Cytokine Profiles as Predictive Markers of IgE-Mediated Allergy in Young ChildrenEfficacy and safety of topical halometasone in eczematous dermatoses in Indian population: an open label, noncomparative study.Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study
P2860
Q24201373-0912CFC3-62A2-401F-BC4A-2F35708B1B32Q24597375-DEFC7697-789E-49B6-B894-E4D1C2FF91CEQ24672988-B675BA3D-E13F-4404-BCC6-85625EE170FFQ28259055-C7FE65A0-C97D-40F5-98CE-136B2C6627ACQ28385664-157B6578-30AD-43A4-B78B-3232229CED4FQ33395681-91941991-E6C2-4B67-A8E1-C3C7FD2142D3Q33638640-B3F53BD0-ECF3-47A3-9001-A24383295B42Q33655045-C60BF3C7-C431-46C8-966E-C15A0B2D838DQ33742782-CBFA6B55-DBB2-4FB7-91CB-E3CAD435172BQ33758839-FAB181B0-4F56-4E75-A42F-809A2E77D48EQ33785053-777D8C17-069F-4633-9FE9-CE3F6EEE1E76Q33817912-E6EFCE99-6D13-49BC-8B30-82EFA88CA4FEQ33884600-9DFB3D00-4F56-452A-8998-85402C42BC72Q33910639-EBF232D6-1421-4691-B399-408F49897400Q33921708-EB27B474-E4F3-450C-9154-0F4837032CA1Q33922867-656274DD-CFE2-4999-A4EC-FF449287E347Q34064583-0716128F-50CF-458A-8A67-048CC30E1DF0Q34097905-E9447886-261C-4B97-8B4B-A53F02903D6BQ34099095-3AC8D404-BF99-4688-A309-7DB95F48B6A7Q34102847-37D8B11F-7051-45AC-A492-0C8495175554Q34106927-AC497ADB-FC2A-4C05-A3B0-2D20DEBD8737Q34174627-C1C07559-92F5-4F1E-9F9D-B6413B9DBEDAQ34218186-B95802D5-2BB4-47AD-9075-D25B7ECAB120Q34336696-8F9D4D8F-96EA-4330-9A71-E53860289ADBQ34351564-4D0FE7E3-6B08-433F-992F-C0CD68BBA952Q34388802-CC2F17A8-1AFE-403F-8D47-0E04BFA316B5Q34619451-09284F2E-99AF-4602-A443-48DFF0D75358Q34699046-8F90E0F7-E343-4E30-8E4E-13939778AAF3Q34715232-45DA521C-E8BB-4B96-8610-7618461E4A3EQ34744183-F04F26C2-00D1-4FB9-A567-5C15BA5D1790Q35022799-EC8B8E72-E2CB-447A-AC8C-69842ECAA812Q35028506-D1DBBEE2-0251-4A76-9D82-E785E5E218FDQ35064733-33EDD3D3-3BCE-475D-BDBF-6BB0982622DFQ35215234-CB0298FF-68AD-4ED3-8BA5-9EB9E1D37AB0Q35243069-78897292-12C6-4BFD-B8D6-B8A1C59F0C2BQ35319834-87175A42-584F-43FC-9F6C-F48E8509B638Q35609038-41477E46-2DD1-4608-8432-3302CD26D01FQ35716378-440C0865-4E9E-4C1F-B84A-86F3276D3540Q35749029-E4080C2D-938D-48B1-AA06-88CCB44B61B3Q35929571-58F0A807-2510-4647-93EB-51A7ABDDC920
P2860
The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation.
description
1994 nî lūn-bûn
@nan
1994 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
name
The U.K. Working Party's Diagn ...... dependent hospital validation.
@ast
The U.K. Working Party's Diagn ...... dependent hospital validation.
@en
The U.K. Working Party's Diagn ...... dependent hospital validation.
@nl
type
label
The U.K. Working Party's Diagn ...... dependent hospital validation.
@ast
The U.K. Working Party's Diagn ...... dependent hospital validation.
@en
The U.K. Working Party's Diagn ...... dependent hospital validation.
@nl
prefLabel
The U.K. Working Party's Diagn ...... dependent hospital validation.
@ast
The U.K. Working Party's Diagn ...... dependent hospital validation.
@en
The U.K. Working Party's Diagn ...... dependent hospital validation.
@nl
P2093
P1476
The U.K. Working Party's Diagn ...... dependent hospital validation.
@en
P2093
P304
P356
10.1111/J.1365-2133.1994.TB08532.X
P407
P577
1994-09-01T00:00:00Z